-
Investors Are Watching: Pitney Bowes Inc. (NYSE:PBI), Atmel Corporation (NASDAQ:ATML), Cardinal Health (NYSE:CAH), Northern Dynasty Minerals (NYSEMKT:NAK), Biota Pharmaceuticals (NASDAQ:BOTA)
Pitney Bowes Inc. (NYSE:PBI) Chief Executive Marc B. Lautenbach said Tuesday he expects flat or reduced employment levels next year as the mail and document-services company cuts costs further as it adapts to the digital era. Pitney Bowes Inc. (NYSE:PBI) in last trading activity advanced 4.77% to close at $25.24. Company weekly performance is -0.16%…
-
Trending Stocks: Altria Group Inc. (NYSE:MO), Yandex N.V. (NASDAQ:YNDX), Franklin Resources Inc. (NYSE:BEN), Global Ship Lease (NYSE:GSL), Biota Pharmaceuticals (NASDAQ:BOTA)
Altria Group (NYSE:MO) EVP John R. Nelson sold 1,640 shares of Altria Group stock in a transaction that occurred on Monday, November 17th. The stock was sold at an average price of $49.06, for a total value of $80,458.40. Following the sale, the executive vice president now directly owns 407,288 shares of the company’s stock,…
-
Investors Watch List: Plains All American Pipeline (NYSE:PAA), Net Element International (NASDAQ:NETE), Ever-Glory International (NYSEMKT:EVK), Biota Pharmaceuticals (NASDAQ:BOTA), Tesla Motors Inc (NASDAQ:TSLA)
Plains All American Pipeline, L.P. (NYSE:PAA) EVP John R. Rutherford sold 8,225 shares of Plains All American Pipeline, L.P. stock in a transaction dated Wednesday, November 19th. The shares were sold at an average price of $53.70, for a total value of $441,682.50. Following the sale, the executive vice president now directly owns 60,800 shares…
-
Hot Watch List: Aldeyra Therapeutics (NASDAQ:ALDX), Wells Fargo & Company (NYSE:WFC), Prologis (NYSE:PLD), Biota Pharmaceuticals (NASDAQ:BOTA), IberiaBank Corp. (NASDAQ:IBKC)
For the third quarter of 2014, Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) reported net losses attributable to common stockholders of approximately $2.0 million compared to net income of approximately $878,000 for the third quarter of 2013. Basic and diluted net loss per share was $0.36 for the three months ended September 30, 2014 compared to basic net…
-
Watch List: Biota Pharmaceuticals (NASDAQ:BOTA), Dicerna Pharmaceuticals (NASDAQ:DRNA), Tessera Technologies Inc. (NASDAQ:TSRA), Apple Inc. (NASDAQ:AAPL), Vodafone Group Plc (ADR) (NASDAQ:VOD)
On November 7, Biota Pharmaceuticals, Inc. (Nasdaq:BOTA) announced its financial results for the three month period ended September 30, 2014. The Company reported a net loss of $6.9 million for the three month period ended September 30, 2014, as compared to a net loss of $3.9 million in the same period of 2013. The $3.0…
-
Top Wall Street Stories: Biota Pharmaceuticals (NASDAQ:BOTA), Rite Aid Corporation (NYSE:RAD), Astea International (NASDAQ:ATEA), Parker-Hannifin (NYSE:PH), Global Brass and Copper (NYSE:BRSS)
Biota Pharmaceuticals, Inc. (NASDAQ:BOTA) announced that management will host a conference call on Friday, November 7, 2014 at 9:00 a.m. EST to review the Company’s first quarter financial results and provide an update on recent corporate developments. Biota Pharmaceuticals, Inc. (NASDAQ:BOTA) in last trading activity moved down -2.10% to close at $2.33. Company weekly performance…
-
Biotech Top gainers – Biota Pharmaceuticals (NASDAQ:BOTA), Agenus (NASDAQ:AGEN), Celsion Corporation (NASDAQ:CLSN), Insmed Incorporated (NASDAQ:INSM)
Biota Pharmaceuticals Inc. (NASDAQ:BOTA) has reported that Daiichi Sankyo Company, Limited (“Daiichi Sankyo”) has been granted regulatory approval in Japan to manufacture and market Inavir(R) Dry Powder Inhaler 20mg (generic name laninamivir octanoate) for the prevention of influenza A and B. Shares of Biota Pharmaceuticals Inc. (NASDAQ:BOTA) closed at $ 4.26during last trading session. The…